                         SEQUENCE LISTING

<110>  ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF 
       ARIZONA)
       Khanna, May
 
<120>  DEVELOPMENT OF APTAMERS FOR NEUTRALIZING ANTIBODIES IN 
       DEMYELINATING DISEASES

<130>  UNIA 21.04 PCT

<160>  7     

<170>  PatentIn version 3.5

<210>  1
<211>  65
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  NM02 aptamer

<400>  1
tagggaagag aaggacatat gattgattgt ccctgttata cgtttgacta gtacatgacc       60

acttg                                                                   65


<210>  2
<211>  65
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  NM01 aptamer

<400>  2
tagggaagag aaggacatat gatgcggtta cctgtgtgac cattgactag tacatgacca       60

cttga                                                                   65


<210>  3
<211>  65
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  NM03 aptamer

<400>  3
tagggaagag aaggacatat gatgcatcta ctcaacccga ttttgactag tacatgacca       60

cttga                                                                   65


<210>  4
<211>  62
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  NM04 aptamer

<400>  4
tagggaagag aaggacatat gatgcggttt acaccgggtt tgactagtac atgaccactt       60

ga                                                                      62


<210>  5
<211>  63
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  NM05 aptamer

<400>  5
tagggaagag aaggacatat gatgattgta actgttcgtt ttgactagta catgaccact       60

tga                                                                     63


<210>  6
<211>  23
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Forward primer

<400>  6
tagggaagag aaggacatat gat                                               23


<210>  7
<211>  23
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Reverse Primer

<400>  7
tcaagtggtc atgtactagt caa                                               23


